Epigenetic Programing of B-Cell Lymphoma by BCL6 and Its Genetic Deregulation
B cell lymphoma is a clinically heterogeneous and pathologically diverse group of diseases with a strong epigenetic component. The B cell lymphoma 6 (BCL6) gene encodes a transcription factor that is critical for normal germinal center reaction B cell development by maintaining an epigenetic and tra...
Main Authors: | Haopeng Yang, Michael R. Green |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcell.2019.00272/full |
Similar Items
-
The Status and Prospects of Epigenetics in the Treatment of Lymphoma
by: Jiaxin Liu, et al.
Published: (2022-04-01) -
Histone Modifications and Other Facets of Epigenetic Regulation in Trypanosomatids: Leaving Their Mark
by: Swati Saha
Published: (2020-10-01) -
Epigenetics and Early Development
by: Gokul Gopinathan, et al.
Published: (2022-06-01) -
Epigenetic Regulation of the Cell Type-Specific Gene 14-3-3σ
by: Marc M.^Oshiro, et al.
Published: (2005-09-01) -
Alternative Splicing, Epigenetic Modifications and Cancer: A Dangerous Triangle, or a Hopeful One?
by: Francisco Gimeno-Valiente, et al.
Published: (2022-01-01)